What Is Regenerative Medicine? Questions to Ask

Regenerative medicine is a broad field focused on approaches that may support the body’s response to injury or disease. It can include research and clinical care involving biologic materials, tissue engineering, cell-based products, or other strategies intended to support repair or function. The term does not describe one standardized treatment, and outcomes depend on the condition, product, and person receiving care.
If you are considering regenerative care, the most useful first step is an informed consultation. A qualified clinician should connect the proposed treatment to your diagnosis, goals, medical history, alternatives, and the evidence that applies to your specific situation. For adults considering care in Richmond, VA, the following questions can help you understand that conversation.
Discuss your regenerative medicine questions with Sigma Core Medical Center
Key Takeaways
- Regenerative medicine is a category, not a single procedure. Ask exactly what product or procedure is being proposed and what it is intended to do.
- Evidence and regulatory status vary by product, condition, and use. Ask what research supports the recommendation and what remains uncertain.
- A careful evaluation should come before a treatment decision. Diagnosis, risks, alternatives, follow-up, and meaningful measures of progress all deserve attention.
What Does Regenerative Medicine Mean?
The phrase “regenerative medicine” generally refers to efforts to repair, replace, or support damaged cells, tissues, or organs. The field includes established medical uses, active research, and treatments whose evidence is still developing. Depending on the context, people may use the term when discussing platelet-rich plasma (PRP), cell-based products, tissue engineering, biomaterials, or related biologic approaches.
These approaches are not interchangeable. PRP is prepared from a person’s blood and contains concentrated platelets and other blood components. A cell-based product may involve cells or tissue from an autologous or donor source, with differences in collection, processing, storage, and delivery. The name of a treatment alone does not tell you whether it is appropriate for a particular diagnosis.
Regenerative care should be discussed as one possible part of a broader plan. Depending on the condition, a plan may also include conservative care, medication, lifestyle changes, another procedure, specialist care, or watchful waiting. The goal of a consultation is not to assume that an injection or biologic is the answer. It is to determine whether a proposed option fits your needs and preferences.
What Can Regenerative Medicine and Its Evidence Tell You?
Research is investigating how biologic materials and cell-based approaches may influence inflammation, signaling, tissue environment, and function. Evidence can differ substantially by body area, diagnosis, preparation method, dose, delivery technique, and the outcome being measured. Findings from one condition or product should not automatically be applied to another.
Ask the clinician to separate what is known from what is being studied. A responsible explanation should cover the quality and limits of the evidence, the expected time course if one is known, and what outcomes would count as meaningful for you. Pain scores may matter, but so may walking tolerance, sleep, strength, work, exercise, or the ability to participate in daily activities.
Be cautious with claims that present a treatment as certain to restore tissue or produce a particular outcome. Individual responses vary, and some proposed uses have limited or mixed evidence. A consultation should leave room for uncertainty and for the possibility that another option, including no procedure, may be more appropriate.
Questions to Ask Before a Regenerative Medicine Consultation
1. What diagnosis are we treating?
Ask how the clinician determined the likely source of your symptoms and whether more than one problem may be involved. A scan can show structural changes without proving that the finding is the cause of pain or loss of function. The evaluation may include your history, a physical examination, movement and strength testing, and imaging or other testing when appropriate.
Also ask whether any symptoms require a different level of care. New or progressive weakness, loss of bladder or bowel control, numbness in the groin area, fever, major trauma, or rapidly worsening symptoms may call for prompt medical evaluation rather than an elective consultation.
2. What exactly is the product or procedure?
Ask for the plain-language name of the proposed treatment and how it would be delivered. For PRP, you can ask how the blood sample is prepared and what components are retained. For a cell-based or donor-derived product, ask about the source, collection, processing, storage, testing, and handling. Ask where the treatment would be placed and whether image guidance is planned.
“Stem cell,” “biologic,” and “regenerative” can refer to different products and procedures. A clear answer should identify what would actually be used, not just repeat a marketing label.
3. What evidence supports this use for my condition?
Ask whether research supports the specific product, diagnosis, treatment site, and intended outcome under discussion. You can ask what type of evidence is available, how recent it is, and whether the results apply to people with a similar medical history. It is reasonable to ask for sources you can read and to ask what the studies do not show.
For general background, the National Eye Institute’s regenerative medicine resource explains the field and distinguishes research from established treatment. The NIH Stem Cell Information resource also points patients toward clinical-trial information and consumer education.
4. What are the potential benefits, risks, and uncertainties?
Ask what improvement is reasonably possible, what side effects can occur, and what is still unknown. Risks may relate to the product, the collection or preparation process, the injection or procedure, infection, bleeding, reactions, or delayed care for another condition. The relevant risks depend on the proposed treatment and your health history.
Ask what symptoms should prompt a call, how complications would be managed, and who would provide follow-up. You should not have to rely on a general statement that a treatment is “natural” or uses your own cells. Autologous material can still involve procedure-related risks, and a biologic approach is not automatically risk-free.
5. What is the regulatory status and intended use?
Ask whether the product or procedure has the regulatory authorization relevant to the use being discussed, whether it is being studied in a clinical trial, and what oversight applies. Regulatory status is specific to a product and intended use; it should not be implied from the word “regenerative” or from approval for a different condition.
The FDA’s consumer alert on regenerative medicine products warns that patients may encounter misleading claims. It explains that the stem-cell products it identifies as FDA-approved in the United States are blood-forming products derived from umbilical cord blood for disorders affecting blood production, not general orthopedic or pain uses. The FDA also states that there are no FDA-approved exosome products. This information does not determine whether any individual treatment is appropriate for you, but it is a useful reason to ask precise regulatory questions.
6. What are my alternatives?
Ask what reasonable alternatives exist, including conservative care, medication, a different procedure, referral to another specialist, monitoring, or doing nothing for now. Ask what could happen if you wait and how the options compare in likely benefits, risks, recovery, and cost.
A balanced consultation should not frame one treatment as your only opportunity. Your goals and values matter. For example, someone who wants to return to recreational activity may measure progress differently from someone whose priority is sleeping comfortably or remaining independent with daily tasks.
7. How will we measure progress?
Before treatment, ask which outcomes will be tracked and when the plan will be reassessed. Consider measures that are meaningful to your daily life, such as walking distance, lifting ability, sleep, medication use, range of motion, strength, or participation in activities you value.
Ask what happens if the expected improvement does not occur. A clear follow-up plan should explain when you will check in, whether additional supportive care is recommended, and what the next step would be. A clinician cannot know in advance exactly how an individual will respond, but a thoughtful plan can define how decisions will be revisited.
8. What will the full care process involve?
Ask about preparation, the procedure itself, aftercare, activity restrictions, and follow-up care. Confirm who will perform each part of the care and how to contact the office with a concern. If you take blood thinners or have allergies, bleeding risks, an infection, immune problems, or other important conditions, share that information before a procedure is considered.
You should also receive a clear explanation of the total expected financial responsibility before making a decision. Ask whether the proposed service is cash-pay, what is included, and whether follow-up or related care is separate. Avoid making a decision based only on a headline price or a limited-time offer.
How to Evaluate Regenerative Medicine Claims Online
Online descriptions may use the same words for very different products or procedures. Look for a clear explanation of the diagnosis being addressed, the source and handling of the product, the evidence for the specific use, known risks, and the provider’s plan for follow-up. Be cautious when a page relies mainly on testimonials, dramatic before-and-after language, celebrity endorsements, or language suggesting one treatment works for everyone.
Check whether a source distinguishes research from routine care and whether it identifies who is responsible for the information. You can also compare the claim with independent government or academic resources. If the description does not explain limitations or alternatives, treat that as a reason to ask more questions rather than as proof that the treatment is unsafe or effective.
How to Prepare for the Conversation
Bring a list of symptoms, when they began, what makes them better or worse, previous diagnoses, imaging reports, medications and supplements, allergies, relevant medical conditions, and the activities you want to preserve or return to. Write down your most important questions in advance. You may also want a trusted family member or support person present, especially when comparing complex options.
It can help to ask the clinician to explain unfamiliar terms without jargon and to give you time to consider the information. You do not need to decide during the first conversation. If a recommendation is unclear, ask what information would change the decision or whether a second opinion is reasonable.
What a Responsible Consultation Should Provide
A responsible consultation should be specific about the diagnosis, proposed treatment, evidence, risks, alternatives, expected process, and follow-up. It should also acknowledge uncertainty. At Sigma Core Medical Center, the regenerative medicine consultation page is an educational starting point for questions about whether this category of care belongs in your conversation.
General information cannot determine whether a treatment is suitable for you. A qualified clinician must review your individual history and goals before making a recommendation. For adults in Richmond, VA, if you want to discuss your questions and whether a comprehensive evaluation or a free 15-minute discovery conversation may be appropriate, contact Sigma Core Medical Center to start the conversation.
Contact Sigma Core Medical Center about your consultation questions
Sources and Further Reading
- U.S. Food and Drug Administration: Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes
- National Eye Institute: Patient and Public Resources on Regenerative Medicine
- National Institutes of Health: Stem Cell Clinical Trials and Other Information
This article is for general education and is not medical advice. Individual treatment decisions should be made with a qualified healthcare professional after review of your history, examination, goals, and available options.




